Pharming Group (PHAR) Stock Price
Pharming Group Price
Revenue has compounded at 48.9% per year over the past 19 years to 376.13 M USD. Earnings per share have declined at 28.0% per year over the last 7 years. Pharming Group's net margin stands at 0.8%, down from 8.0% several years earlier. Analysts set a median price target of 37.00 USD, implying 278.7% above the current price. Of 14 analysts, 13 rate the stock a buy — an overall Buy consensus.
Pharming Group stock price
Pharming Group business model & stock analysis
Frequently asked questions about Pharming Group
Analysts currently set an average price target of 38.00 USD for the Pharming Group stock (median: 37.00 USD), implying +288.9 % versus the latest price. The consensus is based on 14 analyst ratings.
14 analysts currently rate the Pharming Group stock: 13 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Pharming Group to generate revenue of 378.78 M USD and earnings per share of 0.22 USD.
Converted at the current exchange rate, the Pharming Group share trades at 8.72 EUR (9.77 USD).
The expected revenue of Pharming Group is 378.78 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Pharming Group is 16.56 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Pharming Group is currently 44.71. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Pharming Group stock.
The price-to-sales ratio (P/S) of Pharming Group is currently 1.95. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Pharming Group stock.
The Eulerpool Quality Score for Pharming Group is 5/10.
The ISIN of Pharming Group is US71716E1055. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Pharming Group is PHAR. The ticker symbol is used to trade Pharming Group shares on the stock exchange.
Pharming Group stock
Pharming Group Peer Group
All fundamentals and in-depth analysis of Pharming Group
Our stock analysis for Pharming Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharming Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.